Carol M. Mangione, MD, MSPH, FACP, is the Barbara A. Levey, MD, and Gerald S. Levey, MD, endowed chair in medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA) and professor of public health at the UCLA Fielding School of Public Health. In addition, she serves as director of the UCLA/Drew Resource Center for Minority Aging Research/Center for Health Improvement of Minority Elderly, co-director of the UCLA Robert Wood Johnson Foundation Clinical Scholars Program, associate director of the UCLA Clinical and Translational Sciences (CTSI) and director of the UCLA CTSI Workforce Development Program. Dr. Mangione is also a practicing primary care physician in the UCLA Faculty Practice Group and a professor of medicine and public health at UCLA. She also serves as the national study co-chair for the multicenter program Natural Experiments in Translation for Diabetes, which is sponsored by the Centers for Disease Control and Prevention (CDC), the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) and Patient Centered Outcomes Research Institute (PCORI).

Dr. Mangione’s areas of expertise include diabetes, diabetes prevention, health disparities, aging, public health, health insurance benefit design, and public health policy. She is a member of numerous professional societies and organizations, including the American Society of Clinical Investigation, the Society for General Internal Medicine, the American Geriatrics Society, AcademyHealth, the American Diabetes Association, American College of Physicians and recently appointed to the U.S. Preventative Services Task Force. She was also a member of the Board of Governors for the Pardee RAND Graduate School.

Dr. Mangione was the principal investigator for “The Diabetes Health Plan: A System Level Intervention to Prevent and Treat Diabetes,” funded by the Centers for Disease Control (CDC) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to evaluate the effectiveness of the first disease specific health plan in the United States. This work focused on studying the influence of benefit design on prevention of diabetes, adherence to medications, and control of cardiovascular risk factors among persons with diabetes. Dr. Mangione is the Principal Investigator of the “Managing Your Medication for Education and Daily Support,” (MYMEDS) program which embeds clinical pharmacists in primary care practices to enhance communication, educate, and improve medication adherence for patients with poor control of cardiovascular risk factors and in older adults who have polypharmacy and are struggling with adherence to their medications. She is co-principal investigator of a grant from NIDDK, “A Cluster-Randomized Trial of Pharmacist-Coordinated Implementation of the Diabetes Prevention Program,” which evaluates a primary care based program that uses a shared decision making tool to help patients with pre-diabetes learn about the condition and make treatment choices that will reduce their chance of developing diabetes. Finally, she has recently received an award from CDC and NIDDK entitled “A Partnered Evaluation of United Health Care’s (UHC) Medicaid Plan Innovations for Diabetes Patients” that will evaluate health plan level innovations designed to improve the care of patients with chronic conditions in the Medicaid expansion population.

Dr. Mangione was recognized in 2013 with the UCLA Exceptional Physician Award and in 2005 with the Society of General Internal Medicine Mid-Career Mentorship Award. She serves as a reviewer for the Journal of General Internal Medicine, New England Journal of Medicine, and the Journal of the American Medical Association. Dr. Mangione has authored more than 230 peer-reviewed articles and seven book chapters.

Dr. Mangione received her B.S. from the University of Michigan, Ann Arbor. She earned her M.D. at the University of California, San Francisco and completed her residency at University of California Affiliated Hospitals. Dr. Mangione earned her M.S.P.H. from the Harvard School of Public Health and has completed fellowships at Harvard Medical School.